サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1751238

遠隔ケアの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2025年～2030年

Telecare Market Size, Share & Trends Analysis Report By Type (Activity Monitoring, Remote Medication Management), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
遠隔ケアの市場規模、シェア、動向分析レポート：タイプ別、地域別、セグメント予測、2025年～2030年
出版日: 2025年05月14日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遠隔ケア市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の遠隔ケア市場規模は2025年から2030年にかけて4.79%のCAGRを記録し、2030年には63億4,000万米ドルに達すると推定されています。

遠隔ケアは、主に社会的弱者や高齢者にサービスを提供し、緊急事態が発生した場合にすぐに誰かと連絡を取って助けを求めることができます。さらに、電話からオンラインバーチャル訪問まで、新技術の開発が進むにつれ、現代のヘルスケアサービスの様相が形作られてきました。このように、技術の進歩は市場の成長を促進する上で重要な役割を果たしています。ウェアラブルデバイス、遠隔モニタリングシステム、遠隔医療プラットフォームなどのイノベーションは、リアルタイムの健康モニタリング、バーチャル診察、遠隔患者管理を可能にすることで、ヘルスケア提供に革命をもたらしています。例えば、2023年6月、Telecare社は、電子処方箋のためのオーストラリアのスタンドアローン・プラットフォームであるRxPadを発表しました。

臨床医が臨床医のために設計したこの革新的なソリューションは、従来の紙の処方箋に取って代わることを目指しています。RxPadはヘルスケアの提供に革命をもたらし、患者の体験を改善し、医師に力を与えることで、関係者全員にとって診察がより効率的で楽しいものになります。この革新的なデバイスは、市場で最も先進的な機能を提供しています。さらに、高齢化人口の増加が市場拡大の大きな要因となっています。高齢化人口の増加に伴い、ヘルスケアサービス、特に慢性疾患管理や高齢者ケアに対する需要が増加しています。遠隔ケアは、高齢者に継続的なモニタリングとサポートを提供することで、こうした需要に応える実行可能なソリューションを提供します。これにより、高齢患者はタイムリーな医療を受けながら自立した生活を送ることができます。

このような人口動態の変化により、高齢者特有のニーズに対応し、高齢化社会における安全、健康、幸福を促進する遠隔ケアソリューションの大きな市場が形成されつつあります。さらに、慢性疾患の有病率の増加と個別化されたヘルスケアソリューションに対する需要の高まりが、遠隔ケア技術の採用を後押ししています。糖尿病、高血圧、心臓病などの慢性疾患は、継続的なモニタリングと管理が必要であり、遠隔モニタリング・ソリューションによって効果的に促進することができます。遠隔ケアは、予防的な疾病管理、合併症の早期発見、タイムリーな介入を可能にし、長期的には患者の転帰改善と医療費削減につながります。ヘルスケア利害関係者が、利用しやすく、費用対効果が高く、患者中心のヘルスケアサービスを提供する上で、遠隔モニタリングとケアマネジメントソリューションが変革をもたらす可能性を認識していることから、同市場は継続的な成長が見込まれています。

遠隔ケア市場レポートハイライト

  • 遠隔服薬管理分野が2024年に50.97%の最大収益シェアで市場をリード。高齢化、慢性疾患の有病率増加、高齢者向け遠隔ケアアプリの開発、技術の進歩など、いくつかの要因が要因として挙げられます。
  • 活動モニタリング分野は、技術の進歩、ヘルスケアへのアクセスとアウトカムの改善に対する需要の増加により、予測期間中に大きなCAGRで成長すると予測されています。
  • 北米は2024年に49.13%の最大収益シェアで遠隔ケア市場を独占したが、これはスマートフォンとインターネットの高い普及率、身体の健康を維持するための個人の意識の高まり、遠隔ヘルスケアサービスの利用などのいくつかの要因によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 遠隔ケア市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 遠隔ケア：市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析
  • 遠隔ケア市場：医療システム分野における成果と機会
  • 遠隔ケア市場における新興企業と既存企業の分析
  • 国別の規制状況

第4章 遠隔ケア市場セグメント分析、タイプ別、2018年～2030年

  • 定義と範囲
  • タイプ別市場シェア分析、2024年および2030年
  • セグメントダッシュボード
  • 世界の遠隔ケア市場（タイプ別、2018～2030年）
  • アクティビティモニタリング
  • 遠隔投薬管理

第5章 遠隔ケア市場セグメント分析、地域別、2018年～2030年

  • 地域別市場シェア分析、2024年および2030年
  • 地域別市場ダッシュボード
  • 地域別市場のスナップショット
  • 地域別遠隔ケア市場シェア、2024年および2030年
  • 北米
    • 北米の遠隔ケア市場、2018年～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州の遠隔ケア市場、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • アジア太平洋地域の遠隔ケア市場、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの遠隔ケア市場、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの遠隔ケア市場、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業分類
  • Company Position Analysis
  • Company Evaluation Metrix
  • 企業プロファイル
    • Teladoc Health, Inc.
    • Abbott Laboratories
    • Johnson and Johnson
    • AstraZeneca PLC
    • F. Hoffmann-La Roche Ltd.
    • Novartis AG
    • NeoRehab
    • Bristol-Myers Squibb Company
    • GlaxoSmithKline plc
    • Merck and Co., Inc.
    • Pfizer, Inc.
    • Sanofi
    • Samsung Electronics Co. Ltd
    • Qualcomm Technologies, Inc.
    • Orange
    • Google（Alphabet）, Inc
    • Allscripts
    • Apple, Inc.
    • AT&T
    • Airstrip Technologies, Inc
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global telecare market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America telecare market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America telecare market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. telecare market, by type, 2018 - 2030 (USD Million)
  • Table 7 Canada telecare market, by type, 2018 - 2030 (USD Million)
  • Table 8 Mexico telecare market, by type, 2018 - 2030 (USD Million)
  • Table 9 Europe telecare market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe telecare market, by type, 2018 - 2030 (USD Million)
  • Table 11 UK telecare market, by type, 2018 - 2030 (USD Million)
  • Table 12 Germany telecare market, by type, 2018 - 2030 (USD Million)
  • Table 13 France telecare market, by type, 2018 - 2030 (USD Million)
  • Table 14 Italy telecare market, by type, 2018 - 2030 (USD Million)
  • Table 15 Spain telecare market, by type, 2018 - 2030 (USD Million)
  • Table 16 Norway telecare market, by type, 2018 - 2030 (USD Million)
  • Table 17 Denmark telecare market, by type, 2018 - 2030 (USD Million)
  • Table 18 Sweden telecare market, by type, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific telecare market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific telecare market, by type, 2018 - 2030 (USD Million)
  • Table 21 Japan telecare market, by type, 2018 - 2030 (USD Million)
  • Table 22 China telecare market, by type, 2018 - 2030 (USD Million)
  • Table 23 India telecare market, by type, 2018 - 2030 (USD Million)
  • Table 24 Australia telecare market, by type, 2018 - 2030 (USD Million)
  • Table 25 South Korea telecare market, by type, 2018 - 2030 (USD Million)
  • Table 26 Thailand telecare market, by type, 2018 - 2030 (USD Million)
  • Table 27 Latin America telecare market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America telecare market, by type, 2018 - 2030 (USD Million)
  • Table 29 Brazil telecare market, by type, 2018 - 2030 (USD Million)
  • Table 30 Argentina telecare market, by type, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa telecare market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa telecare market, by type, 2018 - 2030 (USD Million)
  • Table 33 South Africa telecare market, by type, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia telecare market, by type, 2018 - 2030 (USD Million)
  • Table 35 UAE telecare market, by type, 2018 - 2030 (USD Million)
  • Table 36 Kuwait telecare market, by type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Telecare market: outlook
  • Fig. 8 Telecare competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Telecare market driver impact
  • Fig. 11 Telecare market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Telecare market: Type movement analysis
  • Fig. 15 Telecare market: Type outlook and key takeaways
  • Fig. 16 Activity Monitoring market estimates and forecast, 2018 - 2030
  • Fig. 17 Remote Medication Management market estimates and forecast, 2018 - 2030
  • Fig. 18 Global telecare market: Regional movement analysis
  • Fig. 19 Global telecare market: Regional outlook and key takeaways
  • Fig. 20 North America telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Key country dynamics
  • Fig. 22 U.S. telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Key country dynamics
  • Fig. 24 Canada telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Key country dynamics
  • Fig. 26 Mexico telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Europe telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 UK telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Germany telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Spain telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Key country dynamics
  • Fig. 35 France telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Key country dynamics
  • Fig. 37 Italy telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Key country dynamics
  • Fig. 39 Norway telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Key country dynamics
  • Fig. 41 Denmark telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Key country dynamics
  • Fig. 43 Sweden telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Japan telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 China telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 India telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Australia telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 South Korea telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Thailand telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Brazil telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Argentina telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 MEA telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Africa telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Saudi Arabia telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 UAE telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Kuwait telecare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key company categorization
  • Fig. 72 Heat map analysis, 2024
目次
Product Code: GVR-4-68039-915-1

Telecare Market Growth & Trends:

The global telecare market size is estimated to reach USD 6.34 billion by 2030, registering a CAGR of 4.79% from 2025 to 2030, according to a new report by Grand View Research, Inc. Telecare provides services mainly to vulnerable and elderly individuals for immediate contact with someone for help in case of any emergency. In addition, the increasing development of new technology, from telephones to online virtual visits, has shaped the face of modern healthcare services. Thus, technological advancements have played a crucial role in driving the market growth. Innovations, such as wearable devices, remote monitoring systems, and telemedicine platforms, have revolutionized healthcare delivery by enabling real-time health monitoring, virtual consultations, and remote patient management. For instance, in June 2023, Telecare introduced RxPad, Australia's standalone platform for electronic prescriptions.

Designed by clinicians for clinicians, this innovative solution aims to replace traditional paper prescriptions. RxPad is poised to revolutionize healthcare delivery, improving patient experiences and empowering doctors, making consultations more efficient and enjoyable for everyone involved. This innovative device offers the most advanced features in the market. Moreover, the growing aging population is a significant factor propelling market expansion. With the growing aging population, the demand for healthcare services increases, particularly for chronic disease management and elderly care. Telecare offers a viable solution to meet these demands by providing continuous monitoring and support for older adults. It enables elderly patients to live independently while ensuring they receive timely medical attention.

This demographic shift is creating a substantial market for telecare solutions that cater to the specific needs of older individuals, promoting safety, health, and well-being in an aging society. Furthermore, the increasing prevalence of chronic diseases and rising demand for personalized healthcare solutions have propelled the adoption of telecare technologies. Chronic conditions, such as diabetes, hypertension, and heart disease, require continuous monitoring and management, which can be effectively facilitated through remote monitoring solutions. Telecare enables proactive disease management, early detection of complications, and timely interventions, leading to improved patient outcomes and reduced healthcare costs in the long run. The market is poised for continued growth as healthcare stakeholders recognize the transformative potential of remote monitoring and care management solutions in delivering accessible, cost-effective, and patient-centered healthcare services.

Telecare Market Report Highlights:

  • The remote medication management segment led the market with the largest revenue share of 50.97% in 2024, attributed to several factors, including the aging population, increased prevalence of chronic diseases, development of elderly telecare apps and technological advancements.
  • The activity monitoring segment is anticipated to grow at the significant CAGR over the forecast period, owing to technological advancements and the increasing demand for improved healthcare access and outcomes.
  • North America dominated the telecare market with the largest revenue share of 49.13% in 2024, attributed to several factors such as the high penetration of smartphones and the internet, growing awareness among individuals to maintain physical health and the use of remote healthcare services.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Telecare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Aging population and elderly care needs for telecare
      • 3.2.1.2. Technological improvements in AI and ML
      • 3.2.1.3. Advances in wearable health technology
      • 3.2.1.4. Growing shift to home healthcare services
      • 3.2.1.5. Increased focus on chronic disease management
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Privacy and security concerns over patient data
      • 3.2.2.2. Complexity of regulatory compliance
      • 3.2.2.3. Lack of standardization across platforms
      • 3.2.2.4. Limited insurance reimbursement for telecare services
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Leveraging ai, big data, and predictive analytics
      • 3.2.3.2. Collaborations with healthcare providers and insurers
      • 3.2.3.3. Increased focus on mental health and remote counseling
    • 3.2.4. Market challenges analysis
      • 3.2.4.1. Connectivity and infrastructure gaps in rural areas
      • 3.2.4.2. Resistance from healthcare providers and traditional systems
  • 3.3. Telecare: Market Analysis Tools
    • 3.3.1. Industry analysis - Porter's
    • 3.3.2. PESTLE analysis
  • 3.4. Telecare Market: Accomplishments and Opportunities Across the Health System Sectors
  • 3.5. Analysis on Start-ups and Established Companies in Telecare Market
  • 3.6. Regulatory Landscape, By Country
    • 3.6.1. Regulatory overview
    • 3.6.2. Health data privacy and security laws
    • 3.6.3. Telemedicine licensing and reimbursement policies
    • 3.6.4. Government initiatives and support
    • 3.6.5. Emerging trends in regulatory compliance
  • 3.7. Value Chain Analysis
    • 3.7.1. Telecare value chain overview
    • 3.7.2. Key stakeholders and their roles
    • 3.7.3. Technology providers and platforms
    • 3.7.4. Service delivery and interoperability
    • 3.7.5. Distribution and supply chain management
    • 3.7.6. Revenue streams and business models
    • 3.7.7. Challenges in the value chain
  • 3.8. Technology Landscape
    • 3.8.1. Technological advancements driving telecare
    • 3.8.2. Telecare software and applications
    • 3.8.3. Data analytics and artificial intelligence
    • 3.8.4. Wearable devices and IoT integration
    • 3.8.5. Telecommunication infrastructure
  • 3.9. Case Study Analysis
  • 3.10. Funding/Investment Trends Scenario
    • 3.10.1. Venture capital (VC) deal activity
    • 3.10.2. Top 10 digital health VC deals in 2024
    • 3.10.3. Annual equity funding & deals
    • 3.10.4. Quarterly equity funding & deals
    • 3.10.5. Quarter funding & deals by global region
    • 3.10.6. Percent of quarterly deals by global region
    • 3.10.7. Percent of quarterly deals by investor group
    • 3.10.8. Annual average & median deal size
    • 3.10.9. Annual median deal size by global region
    • 3.10.10. Annual median deal size by investor group
    • 3.10.11. Annual mega-round funding & deals
    • 3.10.12. Quarterly funding & deals from mega-rounds (deals worth usd 100 million+)
    • 3.10.13. Quarter mega-round funding & deals by global region
    • 3.10.14. Quarterly mega-round deals by global region
    • 3.10.15. Quarterly mega-rounds as percentage of funding
    • 3.10.16. Quarter top equity deals
    • 3.10.17. Annual percentage of deals by deal stage
    • 3.10.18. Quarter regional deal shares by deal stage
    • 3.10.19. Annual median funding by deal stage
    • 3.10.20. Quarter top seed/angel deals
    • 3.10.21. Quarter top series A deals
    • 3.10.22. Quarter top series B deals
    • 3.10.23. Quarter top series C deals
    • 3.10.24. Quarter top series D deals
    • 3.10.25. Quarter top series E+ deals
  • 3.11. Unicorn Funding Trends in Digital Health
    • 3.11.1. Quarterly new & total unicorns (private companies valued at USD 1 billion+)
    • 3.11.2. Quarter new & total unicorns by global region
    • 3.11.3. Quarterly new unicorns by global region
    • 3.11.4. Quarter top unicorns by valuation
  • 3.12. Exit Trends in Digital Health Market
    • 3.12.1. Annual exits
    • 3.12.2. Quarterly exits
    • 3.12.3. Percent of quarterly exits by global region
    • 3.12.4. Quarter top M&A exits
    • 3.12.5. Quarter top IPOs
  • 3.13. Key Investors Analysis in the Digital Health Landscape
    • 3.13.1. Quarter top investors by company count
    • 3.13.2. Quarter top VCs by company count
    • 3.13.3. Quarter top corporate VCs (CVCs) by company count
  • 3.14. Key Investment Geographic Trends in Digital Health Market
    • 3.14.1. U.S. Trends
      • 3.14.1.1. Annual funding & deals
      • 3.14.1.2. Quarterly funding & deals
      • 3.14.1.3. Annual percentage of deals by deal stage
      • 3.14.1.4. Quarter top equity deals
      • 3.14.1.5. Annual exits
      • 3.14.1.6. Quarterly exists
      • 3.14.1.7. Quarter top investors by company count
    • 3.14.2. Asia Trends
      • 3.14.2.1. Annual funding & deals
      • 3.14.2.2. Quarterly funding & deals
      • 3.14.2.3. Annual percentage of deals by deal stage
      • 3.14.2.4. Quarter top equity deals
      • 3.14.2.5. Annual exits
      • 3.14.2.6. Quarterly exists
      • 3.14.2.7. Quarter top investors by company count
    • 3.14.3. China
    • 3.14.4. Japan
    • 3.14.5. Europe Trends
      • 3.14.5.1. Annual funding & deals
      • 3.14.5.2. Quarterly funding & deals
      • 3.14.5.3. Annual percentage of deals by deal stage
      • 3.14.5.4. Quarter top equity deals
      • 3.14.5.5. Annual exits
      • 3.14.5.6. Quarterly exists
      • 3.14.5.7. Quarter top investors by company count
    • 3.14.6. UK

Chapter 4. Telecare Market Segment Analysis, By Type, 2018-2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Telecare Market, by Type, 2018 to 2030
  • 4.5. Activity Monitoring
    • 4.5.1. Activity Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Remote Medication Management
    • 4.6.1. Remote Medication Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Telecare Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Telecare Market Share by Region, 2024 & 2030:
  • 5.5. North America
    • 5.5.1. North America telecare market, 2018 - 2030 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Scenario
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. U.S. telecare market, 2018 - 2030 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Scenario
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Canada telecare market, 2018 - 2030 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Scenario
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Mexico telecare market, 2018 - 2030 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe telecare market, 2018 - 2030 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Scenario
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. UK telecare market, 2018 - 2030 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Scenario
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Germany telecare market, 2018 - 2030 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Scenario
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. France telecare market, 2018 - 2030 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Scenario
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Italy telecare market, 2018 - 2030 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Scenario
      • 5.6.6.3. Competitive Scenario
      • 5.6.6.4. Spain telecare market, 2018 - 2030 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Scenario
      • 5.6.7.3. Competitive Scenario
      • 5.6.7.4. Norway telecare market, 2018 - 2030 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Key Country Dynamics
      • 5.6.8.2. Regulatory Scenario
      • 5.6.8.3. Competitive Scenario
      • 5.6.8.4. Sweden telecare market, 2018 - 2030 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Key Country Dynamics
      • 5.6.9.2. Regulatory Scenario
      • 5.6.9.3. Competitive Scenario
      • 5.6.9.4. Denmark telecare market, 2018 - 2030 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Asia Pacific telecare market, 2018 - 2030 (USD Million)
    • 5.7.2. Japan
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Scenario
      • 5.7.2.3. Competitive Scenario
      • 5.7.2.4. Japan telecare market, 2018 - 2030 (USD Million)
    • 5.7.3. China
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Scenario
      • 5.7.3.3. Competitive Scenario
      • 5.7.3.4. China telecare market, 2018 - 2030 (USD Million)
    • 5.7.4. India
      • 5.7.4.1. Key Country Dynamics
      • 5.7.4.2. Regulatory Scenario
      • 5.7.4.3. Competitive Scenario
      • 5.7.4.4. India telecare market, 2018 - 2030 (USD Million)
    • 5.7.5. Australia
      • 5.7.5.1. Key Country Dynamics
      • 5.7.5.2. Regulatory Scenario
      • 5.7.5.3. Competitive Scenario
      • 5.7.5.4. Australia telecare market, 2018 - 2030 (USD Million)
    • 5.7.6. South Korea
      • 5.7.6.1. Key Country Dynamics
      • 5.7.6.2. Regulatory Scenario
      • 5.7.6.3. Competitive Scenario
      • 5.7.6.4. South Korea telecare market, 2018 - 2030 (USD Million)
    • 5.7.7. Thailand
      • 5.7.7.1. Key Country Dynamics
      • 5.7.7.2. Regulatory Scenario
      • 5.7.7.3. Competitive Scenario
      • 5.7.7.4. Thailand telecare market, 2018 - 2030 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Latin America telecare market, 2018 - 2030 (USD Million)
    • 5.8.2. Brazil
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Scenario
      • 5.8.2.3. Competitive Scenario
      • 5.8.2.4. Brazil telecare market, 2018 - 2030 (USD Million)
    • 5.8.3. Argentina
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Scenario
      • 5.8.3.3. Competitive Scenario
      • 5.8.3.4. Argentina telecare market, 2018 - 2030 (USD Million)
  • 5.9. MEA
    • 5.9.1. MEA telecare market, 2018 - 2030 (USD Million)
    • 5.9.2. South Africa
      • 5.9.2.1. Key Country Dynamics
      • 5.9.2.2. Regulatory Scenario
      • 5.9.2.3. Competitive Scenario
      • 5.9.2.4. South Africa telecare market, 2018 - 2030 (USD Million)
    • 5.9.3. Saudi Arabia
      • 5.9.3.1. Key Country Dynamics
      • 5.9.3.2. Regulatory Scenario
      • 5.9.3.3. Competitive Scenario
      • 5.9.3.4. Saudi Arabia telecare market, 2018 - 2030 (USD Million)
    • 5.9.4. UAE
      • 5.9.4.1. Key Country Dynamics
      • 5.9.4.2. Regulatory Scenario
      • 5.9.4.3. Competitive Scenario
      • 5.9.4.4. UAE telecare market, 2018 - 2030 (USD Million)
    • 5.9.5. Kuwait
      • 5.9.5.1. Key Country Dynamics
      • 5.9.5.2. Regulatory Scenario
      • 5.9.5.3. Competitive Scenario
      • 5.9.5.4. Kuwait telecare market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Position Analysis
  • 6.4. Company Evaluation Metrix
  • 6.5. Company Profiles
    • 6.5.1. Teladoc Health, Inc.
      • 6.5.1.1. Company overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Abbott Laboratories
      • 6.5.2.1. Company overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. Johnson and Johnson
      • 6.5.3.1. Company overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. AstraZeneca PLC
      • 6.5.4.1. Company overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. F. Hoffmann-La Roche Ltd.
      • 6.5.5.1. Company overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Novartis AG
      • 6.5.6.1. Company overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. NeoRehab
      • 6.5.7.1. Company overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Bristol-Myers Squibb Company
      • 6.5.8.1. Company overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. GlaxoSmithKline plc
      • 6.5.9.1. Company overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Merck and Co., Inc.
      • 6.5.10.1. Company overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Pfizer, Inc.
      • 6.5.11.1. Company overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Sanofi
      • 6.5.12.1. Company overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. Samsung Electronics Co. Ltd
      • 6.5.13.1. Company overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Qualcomm Technologies, Inc.
      • 6.5.14.1. Company overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives
    • 6.5.15. Orange
      • 6.5.15.1. Company overview
      • 6.5.15.2. Financial performance
      • 6.5.15.3. Product benchmarking
      • 6.5.15.4. Strategic initiatives
    • 6.5.16. Google (Alphabet), Inc
      • 6.5.16.1. Company overview
      • 6.5.16.2. Financial performance
      • 6.5.16.3. Product benchmarking
      • 6.5.16.4. Strategic initiatives
    • 6.5.17. Allscripts
      • 6.5.17.1. Company overview
      • 6.5.17.2. Financial performance
      • 6.5.17.3. Product benchmarking
      • 6.5.17.4. Strategic initiatives
    • 6.5.18. Apple, Inc.
      • 6.5.18.1. Company overview
      • 6.5.18.2. Financial performance
      • 6.5.18.3. Product benchmarking
      • 6.5.18.4. Strategic initiatives
    • 6.5.19. AT&T
      • 6.5.19.1. Company overview
      • 6.5.19.2. Financial performance
      • 6.5.19.3. Product benchmarking
      • 6.5.19.4. Strategic initiatives
    • 6.5.20. Airstrip Technologies, Inc
      • 6.5.20.1. Company overview
      • 6.5.20.2. Financial performance
      • 6.5.20.3. Product benchmarking
      • 6.5.20.4. Strategic initiatives